The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures. Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project … We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission. Surveillance Population frequency of gene variants predisposing to specific diseases Population frequency of morbidity and mortality from such diseases Population frequency and effects of environmental factors known to interact with gene variants Economic costs of genetic components of diseases Coverage, access, and uptake of genetic tests and services Aetiology Magnitude of disease risk associated with gene variants in different populations Contribution of gene variants to the overall level of disease in different populations Magnitude of disease risk associated with gene–gene and gene–environment interactions in different populations Heal
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The essence of an MR design is that the association between a genetic variant (G) and an outcome (Y) can be used to test whether and by how much the exposure of interest (X) influences the outcome, provided that the genetic variant is associated with the exposure of interest and has no other source of association with the outcome.1,9”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“When initially presented, it was concluded that “[MR] offers a more robust approach to understanding the effect of some modifiable exposures on health outcomes than does much conventional observational epidemiology”1 and that where possible, RCTs should follow to establish the effects of interventions. This conclusion remains unchanged, although moving towards formal triangulation of all pertinent”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Canalization can occur when polymorphic phenotypes expressed during fetal development lead to the development of compensating pathways to mitigate the effects of that expression. 1,178,179”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Estimating effect sizes through the instrumental variable approach imposes a fourth assumption, usually homogeneity of effects of the exposure on the outcome.16 58 59 60”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Most MR studies rely on three core IV assumptions (relevance, independence, and exclusion restriction; fig 1, box 3) to carry out testing for causal effects of the exposure on the outcome.16”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Similarly, violation of the ‘exclusion restriction criteria’33–37 could bias causal estimates in IV analyses when used to test effects of intermediates in RCTs or when used in observational data (including MR)”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“but may be confounded by population stratification.33,34”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“Human genetics can provide compelling evidence of causation through approaches such as Mendelian randomization (MR).”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Performed well, such studies called Mendelian randomization (MR) analyses, can provide rigorous evidence of causation 9,10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“We can exploit the properties of the human genome (specifically, the random segregation of alleles and their non-modifiable nature) to make causal inferences about the relationships between risk factors and disease 10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
In the citing paper
“If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,679
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Flagged first, then by citations
Research works printed but not linked: 3
- Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000.
- http://www.ncbi.nlm.nih.gov/Omim (accessed 12 Dec 2002).
- Heart Protection Study Collaborative Group. MRC/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7–22. · DOI · Paper page
Cited by
Sorted by citations
Items 501–600 of 1,037
The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis
Abilleira, S., Bevan, S., & Markus, H. S. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.040808 · Cited by 122
Boes, E., Coassin, S., Kollerits, B., Heid, I. M., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.003 · Cited by 122
Paige, E., Masconi, K. L., Tsimikas, S., Kronenberg, F., Santer, P., Weger, S., Willeit, J., Kiechl, S. J., & Willeit, P. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0520-z · Cited by 121
Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma
Riscal, R., Bull, C. J., Mesaros, C., Finan, J. M., Carens, M., Ho, E. S., Xu, J. P., Godfrey, J., Brennan, P., Johansson, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0211 · Cited by 122
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
Pazoki, R., Vujković, M., Elliott, J., Εvangelou, Ε., Gill, D., Ghanbari, M., van der Most, P. J., Pinto, R. C., Wielscher, M., Farlik, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22338-2 · Cited by 116
Effects of BMI, Fat Mass, and Lean Mass on Asthma in Childhood: A Mendelian Randomization Study
Granell, R., Henderson, A. J., Evans, D. M., Smith, G. D., Ness, A., Lewis, S. J., Palmer, T., & Sterne, J. A. C. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001669 · Cited by 121
Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling
Emdin, C. A., Khera, A. V., Klarin, D. M., Natarajan, P., Zekavat, S. M., Nomura, A., Haas, M. E., Aragam, K. G., Ardissino, D., Wilson, J. G., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028021 · Cited by 121
Wingo, T. S., Cutler, D. J., Wingo, A. P., Le, N.-A., Rabinovici, G. D., Miller, B. L., Lah, J. J., & Levey, A. I. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0648 · Cited by 119
Khoury, M. J., Little, J., GWINN, M. L., & Ioannidis, J. P. A. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl253 · Cited by 119
Burgess, S. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.26250 · Cited by 118
Khandaker, G. M., Zammit, S., Burgess, S., Lewis, G., & Jones, P. B. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.11.020 · Cited by 118
Brion, M., Leary, S. D., Lawlor, D. A., Smith, G. D., & Ness, A. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31816fdbd3 · Cited by 118
Smulders, Y. M., & Blom, H. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9151-1 · Cited by 119
Education and lung cancer: a Mendelian randomization study
Zhou, H., Zhang, Y., Liu, J., Yang, Y., Fang, W., Hong, S., Chen, G., Zhao, S., Zhang, Z., Shen, J., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz121 · Cited by 118
Mendelian Randomization Analysis as a Tool to Gain Insights into Causes of Diseases: A Primer
Tin, A., & Köttgen, A. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020121760 · Cited by 118
Pleiotropy, epistasis and the genetic architecture of quantitative traits
Mackay, T. F. C., & Anholt, R. R. H. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00711-3 · Cited by 125
Causal inference—so much more than statistics
Pearce, N. E., & Lawlor, D. A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw328 · Cited by 114
Genetic determinants of polycystic ovary syndrome: Progress and future directions
Jones, M. R., & Goodarzi, M. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.040 · Cited by 117
C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
Allin, K. H., Nordestgaard, B. G., Zacho, J., Tybjærg‐Hansen, A., & Bojesen, S. E. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp459 · Cited by 118
C-reactive protein and risk of breast cancer: A systematic review and meta-analysis
Guo, L., Liu, S., Zhang, S., Chen, Q., Zhang, M., Quan, P., Lu, J.-B., & Sun, X. (2015) · Scientific Reports · doi:10.1038/srep10508 · Cited by 117
Spiller, W., Davies, N. M., & Palmer, T. M. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy195 · Cited by 116
LifeGene—a large prospective population-based study of global relevance
Almqvist, C., Adami, H., Franks, P. W., Groop, L., Ingelsson, E., Kere, J., Lissner, L., Litton, J., Maeurer, M. J., Michaëlsson, K., et al. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9521-x · Cited by 116
Titova, O. E., Michaëlsson, K., & Larsson, S. C. (2020) · Stroke · doi:10.1161/strokeaha.120.029902 · Cited by 118
Boccia, S., Hung, R. J., Ricciardi, W., Gianfagna, F., Ebert, M., Fang, J., Gao, C., Götze, T., Graziano, F., Lacasaña‐Navarro, M., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm344 · Cited by 116
Nutrigenetics in Cancer Research—Folate Metabolism and Colorectal Cancer
Ulrich, C. M. (2005) · Journal of Nutrition · doi:10.1093/jn/135.11.2698 · Cited by 116
Sanderson, E., Richardson, T. G., Hemani, G., & Davey Smith, G. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyaa288 · Cited by 115
Lawlor, D. A. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys209 · Cited by 114
Advances in Blood Pressure Genomics
Munroe, P. B., Barnes, M. R., & Caulfield, M. J. (2013) · Circulation Research · doi:10.1161/circresaha.112.300387 · Cited by 117
Angelakopoulou, A., Shah, T., Sofat, R., Shah, S. H., Berry, D. J., Cooper, J. A., Palmen, J., Tzoulaki, I., Wong, A., Jefferis, B. J. M. H., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr225 · Cited by 114
Genetically decreased vitamin D and risk of Alzheimer disease
Mokry, L. E., Ross, S. A., Morris, J. A., Manousaki, D., Forgetta, V., & Richards, J. B. (2016) · Neurology · doi:10.1212/wnl.0000000000003430 · Cited by 114
Bovijn, J., Jackson, L. M., Censin, J. C., Chen, C., Laisk, T., Laber, S., Ferreira, T. C., Pulit, S. L., Glastonbury, C. A., Smoller, J. W., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.11.004 · Cited by 114
Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes
Walker, V. M., Davies, N. M., Hemani, G., Zheng, J., Haycock, P., Gaunt, T. R., Smith, G. D., & Martin, R. M. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15334.1 · Cited by 113
Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan
Kono, S. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200404000-00006 · Cited by 113
C-reactive protein and all-cause mortality--the Copenhagen City Heart Study
Zacho, J., Tybjærg–Hansen, A., & Nordestgaard, B. G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq103 · Cited by 114
Lipoprotein(a) and ischemic heart disease—A causal association? A review
Kamstrup, P. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.036 · Cited by 112
Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization
Smith, G. D., Timpson, N. J., & Ebrahim, S. B. J. (2008) · Annals of Medicine · doi:10.1080/07853890802010709 · Cited by 112
Self-citationKONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 112
Intelligence, health and death
Deary, I. J., Hill, W. D., & Galé, C. R. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01078-9 · Cited by 111
The HUNT study: A population-based cohort for genetic research
Brumpton, B. M., Graham, S. E., Surakka, I. L., Skogholt, A. H., Løset, M., Fritsche, L. G., Wolford, B. N., Zhou, W., Nielsen, J. B., Holmen, O. L., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100193 · Cited by 115
Sacerdote, C., Guarrera, S., Smith, G. D., Grioni, S., Krogh, V., Masala, G., Mattiello, A., Palli, D., Panico, S., Tumino, R., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm113 · Cited by 111
Kunutsor, S. K., Apekey, T. A., Hemelrijck, M. V., Calori, G., & Perseghin, G. (2014) · International Journal of Cancer · doi:10.1002/ijc.29084 · Cited by 109
Sequeira, M., Lewis, S. J., Bonilla, C., Smith, G. D., & Joinson, C. J. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.168617 · Cited by 118
Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis
Yarmolinsky, J., Bonilla, C., Haycock, P., Langdon, R., Lotta, L. A., Langenberg, C., Relton, C. L., Lewis, S. J., Evans, D. M., Smith, G. D., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy081 · Cited by 107
Zheng, J., Xu, M., Walker, V. M., Yuan, J., Korologou‐Linden, R., Robinson, J. W., Huang, P., Burgess, S., Yeung, S. L. A., Luo, S., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05743-0 · Cited by 112
The relationship between type 2 diabetes and dementia
Strachan, M. W. J., Reynolds, R. M., Frier, B. M., Mitchell, R. J., & Price, J. F. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn042 · Cited by 114
Dissecting complex disease: the quest for the Philosopher's Stone?
Buchanan, A. V., Weiss, K. M., & Fullerton, S. M. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl001 · Cited by 110
Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
Sliz, E., Kettunen, J., Holmes, M. V., Williams, C. O., Boachie, C., Wang, Q., Männikkö, M., Sebert, S., Walters, R., Lin, K., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034942 · Cited by 109
Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease
Reitz, C., Tosto, G., Mayeux, R. P., Luchsinger, J. A., & the NIA-LOAD/NCRAD Family Study Group and the Alzheimer's Disease Neuroimaging Initiative (2012) · PLoS ONE · doi:10.1371/journal.pone.0050354 · Cited by 109
Fan, Q., Maranville, J., Fritsche, L. G., Sim, X., Cheung, C. M. G., Chen, L. J., Gorski, M., Yamashiro, K., Ahn, J., Laude, A., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx189 · Cited by 111
Is population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?
Lawson, D. J., Davies, N. M., Haworth, S. J., Ashraf, B. H., Howe, L. J., Crawford, A. A., Hemani, G., Smith, G. D., & Timpson, N. J. (2019) · Human Genetics · doi:10.1007/s00439-019-02014-8 · Cited by 106
Lawlor, D. A. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh124 · Cited by 109
Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype
Brennan, P., McKay, J., Moore, L. E., Zaridze, D., Mukeria, A., Szeszenia‐Dąbrowska, N., Lissowska, J., Rudnai, P., Fabiánová, E., Mateș, D., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp162 · Cited by 108
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis
May-Wilson, S., Sud, A., Law, P., Palin, K., Tuupanen, S., Gylfe, A. E., Hänninen, U. A., Cajuso, T., Tanskanen, T. J., Kondelin, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.034 · Cited by 104
Correlation without a cause: an epidemiological odyssey
Smith, G. D., & Phillips, A. N. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa016 · Cited by 109
Cao, Y., Yang, Y., Hu, Q., & Wei, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04474-z · Cited by 109
Alcohol intake and cardiovascular risk factors: A Mendelian randomisation study
Cho, Y., Shin, S.-Y., Won, S., Relton, C. L., Smith, G. D., & Shin, M. (2015) · Scientific Reports · doi:10.1038/srep18422 · Cited by 109
Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease
Manousaki, D., Mokry, L. E., Ross, S. A., Goltzman, D., & Richards, J. B. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001396 · Cited by 110
Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes
Larsson, S. C., Scott, R. A., Traylor, M., Langenberg, C., Hindy, G., Melander, O., Orho‐Melander, M., Seshadri, S. S., Wareham, N. J., & Markus, H. S. (2017) · Neurology · doi:10.1212/wnl.0000000000004173 · Cited by 109
MTHFR C677T and colorectal cancer risk: A meta‐analysis of 25 populations
Hubner, R. A., & Houlston, R. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22440 · Cited by 106
Timpson, N. J., Forouhi, N. G., Brion, M.-J., Harbord, R. M., Cook, D. G., Johnson, P., McConnachie, A., Morris, R. W., Rodriguez, S., Luan, J., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29438 · Cited by 107
Self-citationPierce, B. L., Tong, L., Argos, M., Gao, J., Jasmine, F., Sk, R., Paul-Brutus, R., Rahaman, R. O., Rakibuz-Zaman, M., Parvez, F., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt182 · Cited by 104
Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer
Rodriguez‐Broadbent, H., Law, P., Sud, A., Palin, K., Tuupanen, S., Gylfe, A. E., Hänninen, U. A., Cajuso, T., Tanskanen, T. J., Kondelin, J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30709 · Cited by 103
The genetics of obstructive sleep apnoea
Mukherjee, S., Saxena, R., & Palmer, L. J. (2017) · Respirology · doi:10.1111/resp.13212 · Cited by 112
Genomics and psychological resilience: a research agenda
Choi, K. W., Stein, M. B., Dunn, E. C., Koenen, K. C., & Smoller, J. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0457-6 · Cited by 108
Complex Causal Process Diagrams for Analyzing the Health Impacts of Policy Interventions
Joffe, M., & Mindell, J. S. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.063693 · Cited by 105
Zhai, G., Teumer, A., Stolk, L., Perry, J. R. B., Vandenput, L., Coviello, A. D., Koster, A., Bell, J. T., Bhasin, S., Eriksson, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002025 · Cited by 107
Sofat, R., Hingorani, A. D., Smeeth, L., Humphries, S. E., Talmud, P. J., Cooper, J., Shah, T., Sandhu, M. S., Ricketts, S. L., Boekholdt, S. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.865444 · Cited by 104
Self-citationOnasanya, O., Iyer, G. S., Lucas, E. J., Lin, D. H., Singh, S., & Alexander, G. C. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30215-7 · Cited by 104
Amplification is the primary mode of gene-by-sex interaction in complex human traits
Zhu, C., Ming, M. J., Cole, J. M., Edge, M. D., Kirkpatrick, M., & Harpak, A. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100297 · Cited by 96
Homocysteine: is it a clinically important cardiovascular risk factor?
Lentz, S. R., & Haynes, W. G. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.9.729 · Cited by 105
Rubin, D. B., & van der Laan, M. J. (2008) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1084 · Cited by 105
Methods for Analyzing Multivariate Phenotypes in Genetic Association Studies
Yang, Q., & Wang, Y. (2012) · Journal of Probability and Statistics · doi:10.1155/2012/652569 · Cited by 103
Beesley, L. J., Salvatore, M., Fritsche, L. G., Pandit, A., Rao, A., Brummett, C. M., Willer, C. J., Lisabeth, L. D., & Mukherjee, B. (2019) · Statistics in Medicine · doi:10.1002/sim.8445 · Cited by 109
Sanderson, E. C. M., Richardson, T. G., Morris, T., Tilling, K. M., & Smith, G. D. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010290 · Cited by 100
Addressing the credibility crisis in Mendelian randomization
Burgess, S., Woolf, B. A. R., Mason, A. M., Ala‐Korpela, M., & Gill, D. (2024) · BMC Medicine · doi:10.1186/s12916-024-03607-5 · Cited by 108
Pfister, R., Barnes, D. R., Luben, R., Forouhi, N. G., Bochud, M., Khaw, K., Wareham, N. J., & Langenberg, C. (2011) · Diabetologia · doi:10.1007/s00125-011-2235-0 · Cited by 103
Lawlor, D. A., Harbord, R. M., Timpson, N. J., Lowe, G. D. O., Rumley, A., Gaunt, T. R., Baker, I. A., YARNELL, J. W. G., Mika Kivimaki, B., Meena Kumari, B., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003011 · Cited by 105
Self-citationCigarette smoking behaviour and blood metabolomics
Gu, F., Derkach, A., Freedman, N. D., Landi, M. T., Albanes, D., Weinstein, S. J., Mondul, A. M., Matthews, C. E., Guertin, K. A., Xiao, Q., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv330 · Cited by 104
Genetics of Atopic Dermatitis: From DNA Sequence to Clinical Relevance
Løset, M., Brown, S., Saunes, M., & Hveem, K. (2019) · Dermatology · doi:10.1159/000500402 · Cited by 110
Yarmolinsky, J., Relton, C. L., Lophatananon, A., Muir, K. R., Menon, U., Gentry‐Maharaj, A., Walther, A., Zheng, J., Fasching, P. A., Zheng, W., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002893 · Cited by 107
Causal inference and effect estimation using observational data
Igelström, E., Craig, P., Lewsey, J., Lynch, J. W., Pearce, A., & Katikireddi, S. V. (2022) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2022-219267 · Cited by 103
Jin, Q., Ren, F., Dai, D., Sun, N., Qian, Y., & Song, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121273 · Cited by 103
Tian, H., Mason, A. M., Liu, C., & Burgess, S. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010823 · Cited by 104
Wang, Q., Kangas, A. J., Soininen, P., Tiainen, M., Tynkkynen, T., Puukka, K. S., Ruokonen, A., Viikari, J. S. A., Kähönen, M. A. P., Lehtimäki, T. J., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv093 · Cited by 102
Factorial Mendelian randomization: using genetic variants to assess interactions
Rees, J. M. B., Foley, C. N., & Burgess, S. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz161 · Cited by 101
Tang, B., Yuan, S., Xiong, Y., He, Q., & Larsson, S. C. (2020) · Diabetologia · doi:10.1007/s00125-020-05131-6 · Cited by 105
Dissecting polygenic signals from genome-wide association studies on human behaviour
Abdellaoui, A., & Verweij, K. J. H. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01110-y · Cited by 104
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease
Bottigliengo, D., Foco, L., Seibler, P., Klein, C., König, I. R., & Fabiola Del Greco, M. (2022) · Brain · doi:10.1093/brain/awac193 · Cited by 104
Thomas, P. E., Vedel‐Krogh, S., Nielsen, S. F., Nordestgaard, B. G., & Kamstrup, P. R. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.10.009 · Cited by 106
Treur, J. L., Demontis, D., Smith, G. D., Sallis, H., Richardson, T. G., Wiers, R. W., Børglum, A. D., Verweij, K. J. H., & Munafò, M. R. (2021) · Addiction Biology · doi:10.1111/adb.12849 · Cited by 102
Sattar, N. A., Murray, H. M., Welsh, P. I., Blauw, G. J., Buckley, B. M., Cobbe, S. M., de Craen, A. J. M., Lowe, G. D. O., Jukema, J. W., Macfarlane, P. W., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000099 · Cited by 105
Howe, L. D., Matijasevich, A., Tilling, K. M., Brion, M., Leary, S. D., Smith, G. D., & Lawlor, D. A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys025 · Cited by 101
Yang, Q., Lin, S. L., Kwok, M. K., Leung, G. M., & Schooling, C. M. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy096 · Cited by 100
DiPrete, T. A., Burik, C. A. P., & Koellinger, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707388115 · Cited by 100
Distinct DNA methylation profiles in subtypes of orofacial cleft
Sharp, G. C., Ho, K. M., Davies, A., Stergiakouli, E., Humphries, K., McArdle, W. L., Sandy, J. R., Smith, G. D., Lewis, S. J., & Relton, C. L. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0362-2 · Cited by 102
Role of Matrix Metalloproteinase-8 in Atherosclerosis
Lenglet, S., Mach, F., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/659282 · Cited by 101
Svingen, G. F. T., Ueland, P. M., Pedersen, E. R., Schartum-Hansen, H., Seifert, R., Ebbing, M., Løland, K. H., Tell, G. S., & Nygard, O. K. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301714 · Cited by 100
Davies, N. M., Gaunt, T. R., Lewis, S. J., Holly, J. M. P., Donovan, J., Hamdy, F. C., Kemp, J. P., Eeles, R. A., Easton, D. F., Kote‐Jarai, Z., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0654-9 · Cited by 106
Millard, L. A. C., Davies, N. M., Timpson, N. J., Tilling, K. M., Flach, P. A., & Smith, G. D. (2015) · Scientific Reports · doi:10.1038/srep16645 · Cited by 104
A meta‐analysis of the MTHFR C677T polymorphism and schizophrenia risk
Lewis, S. J., Zammit, S., Gunnell, D., & Smith, G. D. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30170 · Cited by 100
Metadata
- Authors
- Davey Smith, G., & Ebrahim, S.
- ORCID
- Ebrahim, Shah
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106036991
- Cited by
- 5,882
- References
- 179
- Citations by year
- 2026: 333 · 2025: 673 · 2024: 1162 · 2023: 681 · 2022: 453 · 2021: 442 · 2020: 353 · 2019: 235 · 2018: 201 · 2017: 157 · 2016: 163 · 2015: 118 · 2014: 115 · 2013: 94 · 2012: 101
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- Mendelian randomization, genetic epidemiology, environmental factors in disease, causal inference, confounding, reverse causality, linkage disequilibrium, canalization, genetic polymorphism, genetic testing, public health genetics, disease prevention, Human Genome Project, pathogenesis, cancer genetics
- MeSH terms
- Animals, Disease, Environmental Exposure, Genotype, Humans, Polymorphism, Genetic, Molecular Epidemiology, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
